Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
| In millions, except per share items | Mar-31-23 | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 |
| | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| International pharmaceutical distribution and services | | | | | | | | 23,497.0 |
| North America pharmaceutical distribution and services | | | | | | | | 158,469.0 |
| Medical-Surgical distribution and services | | | | | | | | 6,033.0 |
| Distribution Solutions revenues | | | | | | | | 187,999.0 |
| Revenue growth [+] | | | | | | | | 6.8% |
| International pharmaceutical distribution and services | | | | | | | | -10.9% |
| North America pharmaceutical distribution and services | | | | | | | | 10.3% |
| Medical-Surgical distribution and services | | | | | | | | 2.1% |
| EBITDA | | | | | | | | 4,383.0 |
| EBITDA margin | | | | | | | | 2.3% |
| Depreciation and amortization | | | | | | | | 669.0 |
| EBIT | | | | | | | | 3,714.0 |
| EBIT margin | | | | | | | | 2.0% |
| Non-recurring charges | | | | | | | | 161.0 |
| |
| Capital expenditures | | | | | | | | 306.0 |
| |
| Total assets | | | | | | 53,915.0 | 52,322.0 | 47,088.0 |
| ROA | | | | | | 0.0% | 0.0% | 5.4% |
| |
| Revenue Mix | | | | | | | | 98.5% |
| EBIT Mix | | | | | | | | 100.2% |
|